NO20035684L - Immunomodulerende forbindelser - Google Patents

Immunomodulerende forbindelser

Info

Publication number
NO20035684L
NO20035684L NO20035684A NO20035684A NO20035684L NO 20035684 L NO20035684 L NO 20035684L NO 20035684 A NO20035684 A NO 20035684A NO 20035684 A NO20035684 A NO 20035684A NO 20035684 L NO20035684 L NO 20035684L
Authority
NO
Norway
Prior art keywords
compound
relates
present
immunomodulatory compounds
novel heterocyclic
Prior art date
Application number
NO20035684A
Other languages
English (en)
Norwegian (no)
Other versions
NO20035684D0 (no
Inventor
Tomas Fex
Lars Olof Goran Pettersson
Poul Sorensen
Per Axel Bjork
Dorthe Da Graca Thrige
Original Assignee
Active Biotech Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Active Biotech Ab filed Critical Active Biotech Ab
Publication of NO20035684D0 publication Critical patent/NO20035684D0/no
Publication of NO20035684L publication Critical patent/NO20035684L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Transplantation (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Endocrinology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
NO20035684A 2001-07-04 2003-12-19 Immunomodulerende forbindelser NO20035684L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE0102404A SE0102404D0 (sv) 2001-07-04 2001-07-04 Novel immunomodulating compounds
PCT/SE2002/001309 WO2003004495A1 (fr) 2001-07-04 2002-07-02 Nouveaux composes immunomodulateurs

Publications (2)

Publication Number Publication Date
NO20035684D0 NO20035684D0 (no) 2003-12-19
NO20035684L true NO20035684L (no) 2004-03-02

Family

ID=20284743

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20035684A NO20035684L (no) 2001-07-04 2003-12-19 Immunomodulerende forbindelser

Country Status (21)

Country Link
EP (1) EP1409485B1 (fr)
JP (1) JP2005501033A (fr)
CN (1) CN1249063C (fr)
AT (1) ATE324373T1 (fr)
AU (1) AU2002315996B2 (fr)
BR (1) BR0210776A (fr)
CA (1) CA2451749A1 (fr)
DE (1) DE60210977T2 (fr)
ES (1) ES2258150T3 (fr)
HK (1) HK1066809A1 (fr)
HR (1) HRP20031055B1 (fr)
HU (1) HUP0401204A3 (fr)
MX (1) MXPA04000017A (fr)
NO (1) NO20035684L (fr)
NZ (1) NZ530316A (fr)
PL (1) PL367637A1 (fr)
RU (1) RU2004103079A (fr)
SE (1) SE0102404D0 (fr)
WO (1) WO2003004495A1 (fr)
YU (1) YU101603A (fr)
ZA (1) ZA200309806B (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE353898T1 (de) 2002-11-22 2007-03-15 Active Biotech Ab Pyrazolochinoline mit immunmodulierenderwirkung
DE60326639D1 (de) 2002-12-16 2009-04-23 Active Biotech Ab Tetrazyklische immunmodulierende verbindungen
GB0305876D0 (en) * 2003-03-14 2003-04-16 Avidex Ltd Immuno inhibitory heterocyclic compounds
DE602004030225D1 (de) * 2003-03-14 2011-01-05 Medigene Ltd Immunmodulierende heterocyclische verbindungen
GB0325644D0 (en) 2003-11-04 2003-12-10 Avidex Ltd Immuno ihibitory pyrazolone compounds
WO2005068467A1 (fr) 2004-01-14 2005-07-28 Ajinomoto Co., Inc. Nouveau compose a cycle fusionne
GB0411770D0 (en) * 2004-05-26 2004-06-30 Avidex Ltd Immuno inhibitory heterocyclic compouds
DE602004017231D1 (de) 2004-08-09 2008-11-27 Medigene Ltd Immunmodulierende oxopyrazolocinnoline als cd80-inhibitoren
CN101863903B (zh) * 2010-06-08 2014-03-12 沈阳药科大学 1,4-二氢噻吩并[3’,2’:5,6]噻喃并[4,3-c]吡唑-3-羧酸衍生物及其应用
JP6625973B2 (ja) * 2013-06-24 2019-12-25 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツングＭｅｒｃｋ Ｐａｔｅｎｔ Ｇｅｓｅｌｌｓｃｈａｆｔ ｍｉｔ ｂｅｓｃｈｒａｅｎｋｔｅｒ Ｈａｆｔｕｎｇ Ｆｓｈｒの調節剤としてのピラゾール化合物及びその使用
EP2883883A1 (fr) 2013-12-16 2015-06-17 Cardio3 Biosciences S.A. Cibles thérapeutiques et agents utiles dans le traitement des lésions ischémiques de reperfusion
NZ728301A (en) 2014-07-08 2017-09-29 Avertana Ltd Extraction of products from titanium-bearing minerals

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4268516A (en) * 1978-10-11 1981-05-19 Pfizer Inc. [1]Benzothiopyrano[4,3-c]pyrazoles as immunoregulatory agents
US4312870A (en) * 1979-06-21 1982-01-26 Ciba-Geigy Corporation Pyrazoloquinolines
PH26314A (en) * 1988-08-09 1994-04-29 Boots Co Plc Benzopyrano [4,3-c] pyrazoles derivatives
GB8818895D0 (en) * 1988-08-09 1988-09-14 Boots Co Plc Therapeutic agents
SE8903564D0 (sv) * 1989-10-26 1989-10-26 Pharmacia Ab New use condensed quinoline compound
BR9105984A (pt) * 1990-02-02 1992-11-10 Boots Co Plc Processo de preparacao de derivados do pirazol e de composicoes farmaceuticas que contem os mesmos
AR006520A1 (es) * 1996-03-20 1999-09-08 Astra Pharma Prod Derivados de 2-arilpirazolisoquinolina y cinolinona y procedimiento para su preparacion.

Also Published As

Publication number Publication date
HUP0401204A2 (hu) 2004-10-28
BR0210776A (pt) 2004-07-20
YU101603A (en) 2006-05-25
SE0102404D0 (sv) 2001-07-04
CA2451749A1 (fr) 2003-01-16
HUP0401204A3 (en) 2008-03-28
AU2002315996B2 (en) 2007-11-29
JP2005501033A (ja) 2005-01-13
NZ530316A (en) 2004-08-27
CN1522254A (zh) 2004-08-18
NO20035684D0 (no) 2003-12-19
EP1409485A1 (fr) 2004-04-21
MXPA04000017A (es) 2004-05-21
DE60210977D1 (de) 2006-06-01
WO2003004495A1 (fr) 2003-01-16
HRP20031055A2 (en) 2004-06-30
ES2258150T3 (es) 2006-08-16
DE60210977T2 (de) 2006-09-21
HK1066809A1 (en) 2005-04-01
RU2004103079A (ru) 2005-06-10
ZA200309806B (en) 2004-12-20
ATE324373T1 (de) 2006-05-15
PL367637A1 (en) 2005-03-07
HRP20031055B1 (en) 2008-01-31
EP1409485B1 (fr) 2006-04-26
CN1249063C (zh) 2006-04-05

Similar Documents

Publication Publication Date Title
NO20053018L (no) Pyrazoloquinoliner med immunmodulerende aktivitet.
NO20035684D0 (no) Immunomodulerende forbindelser
HK1067120A1 (en) Glutaminyl based dpiv inhibitors
WO2005092895A3 (fr) Composes acide propanoique beta piperidino methyle alpha aryle ou heteroaryle utilises comme antagonistes du recepteur orl1
DE50312946D1 (de) Difluormethyl thiazolyl carboxanilide
WO2004074244A3 (fr) Composes de pyrimidine
WO2008045393A3 (fr) Composés d'imidazo- et de triazolo-pyridine et leurs procédés d'utilisation
DE50306845D1 (de) Disubstituierte thiazolylcarboxanilide und ihre verwendung als mikrobizide
BR0306566B1 (pt) mÉtodo para fabricar escària contendo àxido de titÂnio.
NO20063196L (no) Nye fusjonerte pyrrolokarbazoler
MXPA05009501A (es) Compuestos de azetidinona sustituidos, formulaciones y usos de los mismos para el tratamiento de hipercolesterolemia.
SE0200919D0 (sv) Chemical compounds
HUP0500136A2 (hu) Oxitocin antagonista hatású szubsztituált diketo-piperazinok, eljárás előállításukra, az ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk
WO2005009951A3 (fr) Cycloalcanes diphenyl-substitutes, compositions contenant ces composes, et procedes d'utilisation
WO2003087062A3 (fr) Composes heterocycliques, procede de preparation de ces composes et compositions pharmaceutiques les contenant, et utilisations en medecine
MXPA05007607A (es) Inhibidores amida y ester de la metaloproteinasa de matriz.
ATE356623T1 (de) 5-ht3-rezeptorantagonisten und verwendungsverfahren
DE50310579D1 (de) Furancarboxamide
MXPA05009502A (es) Compuestos de azetidinona sustituidos, formulaciones y usos de los mismos para el tratamiento de hipercolesterolemia.
DE60326639D1 (de) Tetrazyklische immunmodulierende verbindungen
TR200503401T1 (tr) Kuetiapin (Quetiapine) Fumarat'ın yeni polimorfları
HK1061845A1 (en) New process for the industrial synthesis of substituted thiophenecarboxylates, and application of such compounds
DE50311756D1 (de) Mikrobizide oxathiincarboxamide
GB0103045D0 (en) Organic Compounds
WO2004024060A3 (fr) Composes

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application